Plasmablastic lymphoma: current perspectives

A Lopez, P Abrisqueta - Blood and lymphatic cancer: targets and …, 2018 - Taylor & Francis
Plasmablastic lymphoma (PbL) is a rare and aggressive B-cell malignancy with large
neoplastic cells, most of them resembling plasmablasts that have a CD20-negative …

Plasmablastic lymphoma: An update

J Bailly, N Jenkins, D Chetty… - International Journal …, 2022 - Wiley Online Library
Plasmablastic lymphoma (PBL) is a highly aggressive B cell non‐Hodgkin lymphoma
frequently associated with immunosuppression, particularly human immunodeficiency virus …

[HTML][HTML] MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma

JE Ramis-Zaldivar, B Gonzalez-Farre, A Nicolae… - …, 2021 - ncbi.nlm.nih.gov
Plasmablastic lymphoma (PBL) is an aggressive B-cell lymphoma with an
immunoblastic/large-cell morphology and terminal B-cell differentiation. The differential …

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma

F Frontzek, AM Staiger, M Zapukhlyak, W Xu… - Nature …, 2021 - nature.com
Plasmablastic lymphoma (PBL) represents a rare and aggressive lymphoma subtype
frequently associated with immunosuppression. Clinically, patients with PBL are …

Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK–STAT pathway

Z Liu, I Filip, K Gomez, D Engelbrecht, S Meer… - Blood cancer …, 2020 - AACR
Plasmablastic lymphoma (PBL) is an aggressive B-cell non-Hodgkin lymphoma associated
with immunodeficiency in the context of human immunodeficiency virus (HIV) infection or …

Clinical and therapeutic implications of Epstein–Barr virus in HIV-related lymphomas

M Verdu-Bou, G Tapia, A Hernandez-Rodriguez… - Cancers, 2021 - mdpi.com
Simple Summary Epstein–Barr virus (EBV) is involved in lymphomagenesis, especially
lymphomas affecting populations with immunodeficiencies, such as people living with HIV …

The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma

PR Di Ciaccio, MN Polizzotto, K Cwynarski, AS Gerrie… - Blood, 2024 - ashpublications.org
Plasmablastic lymphoma (PBL) is a rare and aggressive non-Hodgkin lymphoma associated
with immunodeficiency, characterized by uncertain treatment approaches and an …

[PDF][PDF] HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases

YJ Li, JW Li, KL Chen, J Li, MZ Zhong, XL Liu… - Blood …, 2020 - synapse.koreamed.org
BLOOD RESEARCH Page 1 This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) …

Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China

D Shi, L Gao, XC Wan, J Li, T Tian, J Hu, QL Zhang… - BMC medicine, 2022 - Springer
Background Plasmablastic lymphoma (PBL) is a rare but aggressive B-cell lymphoma
subtype with poor prognosis. Knowledge about the etiology, clinicopathologic and molecular …

Epstein–Barr virus‐associated lymphomas decoded

K Bednarska, R Chowdhury, JWD Tobin… - British Journal of …, 2024 - Wiley Online Library
Summary Epstein–Barr virus (EBV)‐associated lymphomas cover a range of histological B‐
and T‐cell non‐Hodgkin and Hodgkin lymphoma subtypes. The role of EBV on B‐cell …